摘要
目的研究乌司他丁与丙种球蛋白联用对重症肺炎患者的疗效。方法选择2008年3月至2012年3月我院收治的152例重症肺炎患者，按照随机数表法将所有患者随机分为实验组和对照组各76例。两组患者均予以常规治疗，对照组在此基础上采用丙种球蛋白进行治疗，实验组在对照组的基础上加用乌司他丁进行治疗。结果治疗后，实验组患者的平均退热时间、湿哕音消退时间、呼吸衰竭纠正时间以及住院时间均明显短于对照组，差异有显著性（P〈0．05）；实验组患者的总有效率（89．5％）明显高于对照组（67．1％），实验组临床疗效明显优于对照组（P〈0．05）。结论乌司他丁与丙种球蛋白联合治疗重症肺炎疗效显著，值得临床推广应用。
Objective To study the efficacy of ulinastatin combined with gamma globulin in treatment for patients with severe pneumonia. Methods 152 patients with severe pneumonia from March 2008 to March 2012, in accordance with the law of the random number table, were randomly divided into experimental group and con- trol group, 76 patients in each group. The two groups were treated with conventional therapy, the conventional treatment for severe pneumonia treatment and control group based on gamma globulin treatment; experimental group on the basis of the control group, was treated with ulinastafin. After the treatment, the clinical efficacy of the two groups were observed. Results After treatment, the average cooling time of the patients in the experimental group, moist rales subsided time, respiratory failure to correct time and hospital stay were significantly shorter than those of the control group, the two groups had significant difference （P〈0.05）; the experimental group patients after total efficiency （89.5%） was significantly higher than that of the control group（67.1%）, the clinical efficacy of treat- ment of the experimental group was significantly better than that in the control group （P〈0.05）. Conclusion The efficacy of ulinastatin combined with gamma globulin in treatment for patients with severe pneumonia is signifi- cant, worthy of clinical application.
出处
《国际医药卫生导报》
2013年第2期178-180,共3页
International Medicine and Health Guidance News
